entertainment -WSS

entertainment

author：knowledge 2025-09-28 23:10:56 - browse：98448

Bristol Myers Squibb sign — Courtesy Bristol Myers Squibb

Bristol Myers Squibb will pay $4.1 billion for RayzeBio, the companies said Tuesday, buying into the fast-growing field of using targeted doses of radiation to treat cancer.

RayzeBio, which raised about $350 million in a September initial public offering, is working in radiopharmaceuticals, which pair the tumor-killing power of radiation with the precision of targeted cancer therapies. The company is currently running a pivotal trial of its most advanced drug, RYZ101, in neuroendocrine cancer and has a pipeline of treatments for kidney, liver, and other cancers.

Bristol Myers will pay $62.50 in cash per share of RayzeBio, a roughly 115% premium to the company’s recent trading and more than triple the company’s IPO price.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Coercive sterilizations revealed by STAT prompt outrage

entertainment

Wikipedia

WSS

Pharma companies must ensure equitable access to obesity drugs

Laying a path for careers in science

CDC advisory group OKs chikungunya vaccine

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

Cholera vaccine supplies dangerously low, outbreaks surging

Lilly's Alzheimer's drug donanemab backed by FDA advisers

hotspot

entertainment

explore

Psychedelics group wrestles with new pharma identity

CDC advisory group OKs chikungunya vaccine

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

Apple is now the first public company to be valued at $3 trillion

'Vaccine

Virginia high school admissions case could be legal follow

Doctor of U.S. President Joe Biden says he is fit for duty

Dobbs anniversary: the lost opportunity of abortion as health care

Cheap, fast test for Zika and dengue could cost just $1

hotspot

Cheap, fast test for Zika and dengue could cost just $1

Moderna says combo Covid

5 ways to address the shortage of health care workers

Medicare Advantage isn’t working — for anyone

Study fuels hope CAR

Neuroscience renaissance leads to new crop of psychiatric drugs

entertainment

Wikipedia

knowledge

focus